Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

A Second Set of Eyes

Proscia
By Author Proscia | October 4, 2021

Proscia’s Julianna Ianni, VP of AI R&D, speaks to the tremendous promise of AI in pathology. She notes that beyond improving the accuracy of diagnosis, AI has the potential to shape the way we understand and treat disease. Julianna also comments on the benefits that AI is delivering today, helping pathologists to focus more time where it matters most by driving efficiency and quality gains.

Our website uses cookies. By using this site, you agree to its use of cookies.